#dr lal pathlabs

2 stories

#acquisition #assessment year 2022-23 #biotech #esop expenses #genomic diagnostic services #income tax department #itat #sn genelab #stake purchase #tax relief

I-T Dept Challenges Tax Relief for Dr Lal PathLabs
Income Tax Department appeals Rs 32.66-cr tax relief granted to Dr Lal PathLabs.
The Economic Times · 1m
Dr Lal PathLabs Acquires SN Genelab Stake
Dr Lal PathLabs to buy 70% stake in SN Genelab for Rs 168 crore.
The Economic Times · 1m